BB Biotech Update July 2021

In July, companies began reporting second quarter 2021 earnings. BB Biotech´s share price was slightly positive for the month of July whereas the Net Asset Value and the Nasdaq Biotech Index was slightly negative for the same period. Moderna, a core holding in BB Biotech´s portfolio, was once again in focus in the investor community and the company was added to the prestigious S&P 500 stock index. Moderna replaced Alexion, another BB Biotech portfolio company, that was acquired by pharmaceutical company AstraZeneca.